XML 14 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Millions
Jun. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 3,136 $ 3,730
Accounts receivable, net of allowances of $117 in 2021 and $125 in 2020 2,021 2,007
Inventories 2,065 1,916
Prepaid expenses and other current assets 782 758
Total current assets 8,004 8,411
Property, plant and equipment, net 4,649 4,722
Goodwill 3,148 3,217
Other intangible assets, net 1,910 1,671
Operating lease right-of-use assets 567 603
Other non-current assets 1,404 1,395
Total assets 19,682 20,019
Current liabilities:    
Short-term debt 51 0
Current maturities of long-term debt and finance lease obligations 406 406
Accounts payable 1,005 1,043
Accrued expenses and other current liabilities 1,882 1,884
Total current liabilities 3,344 3,333
Long-term debt and finance lease obligations 5,710 5,786
Operating lease liabilities 469 501
Other non-current liabilities 1,624 1,673
Total liabilities 11,147 11,293
Commitments and contingencies
Equity:    
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2021 and 2020 683 683
Common stock in treasury, at cost, 183,639,786 shares in 2021 and 178,580,208 shares in 2020 (11,561) (11,051)
Additional contributed capital 6,090 6,043
Retained earnings 16,658 16,328
Accumulated other comprehensive (loss) income (3,376) (3,314)
Total Baxter stockholders’ equity 8,494 8,689
Noncontrolling interests 41 37
Total equity 8,535 8,726
Total liabilities and equity $ 19,682 $ 20,019